SHZ · 002412.SZ
Hunan Hansen Pharmaceutical Co., Ltd.
CN¥7.48+CN¥0.03 (+0.4%)
Hunan Hansen Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.43% below the high.
Loading market information…
SHH · 603168.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 41.66% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.’s forward annual dividend is CN¥0.02 per share, paid annual. The forward yield is 0.41% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes. It offers its products in injections, oral solutions, eye drops, large-volume injections, oral solutions, tablets, granules, and other dosage forms. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was founded in 2000 and is based in Pinghu, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:03 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥7.48+CN¥0.03 (+0.4%)
Hunan Hansen Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.43% below the high.
CN¥9.57-CN¥0.02 (-0.21%)
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD’s quoted price sits in the lower half of its reported 52-week range, 54.34% below the high.
CN¥11.33-CN¥0.05 (-0.44%)
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.9% below the high.
CN¥19.41-CN¥0.09 (-0.46%)
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd’s quoted price sits in the lower half of its reported 52-week range, 41.15% below the high.
CN¥16.10-CN¥1.20 (-6.94%)
Guangdong Lifestrong Pharmacy Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.66% below the high.
CN¥3.19CN¥0.00 (0.0%)
Guizhou Yibai Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.47% below the high.
CN¥5.22-CN¥0.05 (-0.95%)
Anhui Fengyuan Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 28.98% below the high.
CN¥3.53-CN¥0.23 (-6.12%)
Chengdu Huasun Technology Group Inc., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.46% below the high.
